Results 141 to 150 of about 21,842 (260)

Effectiveness of Alcohol Use Disorder Pharmacotherapies by Sex: Systematic Review and Meta‐Analysis

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Issues Alcohol use disorder (AUD) shows sex‐related differences in prevalence, harm and treatment response. Despite growing interest in sex differences, evidence synthesis evaluating pharmacotherapy effectiveness by sex remains limited. Approach Web of Science, PubMed, Scopus, PsycINFO and Cochrane were searched twice.
Juliette Allen, Andrew Jones, Gillian W. Shorter, Catharine Montgomery, Zetta Kougiali, Alina Bagnall, Claire Adshead, Jessie Smith, Sam Burton, Amanda Atkinson, Lillian Guelen, Abigail Rose   +11 more
wiley   +1 more source

Bifidobacterium bifidum G9‐1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open‐Label, Randomized Controlled Trial (Binary STAR Study)

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5952-5967, July 2026.
ABSTRACT Aims To evaluate the effects of probiotics Bifidobacterium bifidum G9‐1 (BBG9‐1) on gastrointestinal symptoms in patients with Type 2 diabetes mellitus (T2DM) with diarrhoea or constipation. Materials and Methods In a 12‐week open‐label randomised controlled trial, 100 participants were randomized 1:1 to a control or BBG9‐1 group, with 12 mg ...
Genki Kobayashi, Yoshitaka Hashimoto, Tomoyuki Matsuyama, Noriyuki Kitagawa, Saori Majima, Takafumi Senmaru, Emi Ushigome, Hiroshi Okada, Naoko Nakanishi, Masahide Hamaguchi, Michiaki Fukui   +10 more
wiley   +1 more source

Tratamiento de la emesis inducida por citotóxicos

Psicooncologia, 2004
Nausea and vomiting are important side effects of most chemotherapy anticancer drugs, since nearly two thirds of the patients under chemotherapy have this toxicity in absence of antiemetic treatment.
Miguel Martín, Sara López
doaj  

Gastroenterological Society of Australia Position Statement on the Assessment and Management of Idiopathic Gastroparesis

Journal of Gastroenterology and Hepatology, Volume 41, Issue 7, Page 2043-2061, July 2026.
The first Australian guidance document on the assessment and management of idiopathic gastroparesis (IGP) reconceptualises IGP as a sensorimotor disorder. It proposes a novel multidisciplinary treatment algorithm and 20 high‐consensus recommendations, addressing common overlapping disorders, and providing clear guidance on associated disordered eating ...
Trina Kellar, Chamara Basnayake, Jessica Biesiekierski, Rebecca Burgell, Jessica Fitzpatrick, Geoffrey Hebbard, Vincent Ho, Hannah Kim, Simon R. Knowles, Christopher K. Rayner, May Wong, Nicholas J. Talley   +11 more
wiley   +1 more source

Dispensing of Antiemetics During Pregnancy in Aotearoa New Zealand, 2005-2020. [PDF]

Aust N Z J Obstet Gynaecol
Donald S, Sharples K, Barson D, Maclennan K, Te Karu L, Phone D, van Asten H, Stitely M, Parkin L.   +8 more
europepmc   +1 more source

Factors Influencing Evidence‐Informed Symptom Management in Outpatient Malignant Hematology: A Qualitative Description of Patients' and Nurses' Experiences

Journal of Clinical Nursing, Volume 35, Issue 7, Page 3226-3241, July 2026.
ABSTRACT Aims To describe patients' and oncology nurses' experiences with symptom management care, and influential barriers and facilitators to enhancing evidence‐informed symptom management in an outpatient malignant hematology unit. Design A qualitative descriptive study embedded within an experience‐based co‐design approach.
Kylie Teggart, Denise Bryant‐Lukosius, Sarah E. Neil‐Sztramko, Tammy De Gelder, Kari Kolm, Cheryl Page, Rebecca Ganann   +6 more
wiley   +1 more source

Persistent nausea burden at peak antiemetic therapy in palliative care: an exploratory study. [PDF]

BMC Palliat Care
Pietsch P, Summerer L, Mair R, Müller K, Authier D, Herr W, Rechenmacher M, Schnell A.   +7 more
europepmc   +1 more source

Expert Clinical Consensus on Body Surface Gastric Mapping Phenotypes for Gastroduodenal Disorders: ‘Auckland Classification’ v1.0

Neurogastroenterology &Motility, Volume 38, Issue 7, July 2026.
The Auckland Classification, derived by international consensus, presents a structured framework for BSGM‐defined patient phenotypes. This classification forms a foundation for research, further validation, and a pathway for integrating BSGM into clinical care. ABSTRACT Introduction Chronic gastroduodenal disorders remain challenging to manage, and new
Chris Varghese, Nicky Dachs, Gabriel Schamberg, Thomas Abell, Mohammad Al‐Haddad, Timothy Robert Angeli‐Gordon, Shahin Ayazi, Homira Ayubi, Mohammad Bashashati, Robert Bulat, Stefan Calder, Christopher Brian Cederwall, Bianca Chang, Leo Cheng, John Clarke, Charlotte Daker, Peng Du, Jon Erickson, Sven Eriksson, Asma Fikree, Daphne Foong, Mark Fox, Uday Chand Ghoshal, Mahesh Goenka, Rehan Haidry, William L. Hasler, Bu'Hussain Hayee, Vincent Ho, Gerald Holtman, Anthony Robert Hobson, I‐Hsuan Huang, Daniel Keszthelyi, Sahib S. Khalsa, Natasha Koloski, Braden Kuo, David Kunkel, Mikaela Law, David Levinthal, Joy J. Liu, Prateek Mathur, Baharak Moshiree, Leila Neshatian, Catherine Ngo, Linda Nguyen, Nicholas R. Oblizajek, Henry P. Parkman, Sanjay Pandanaboyana, Alexander Podboy, Ali Rezaie, Amol Sharma, Sam Simmonds, Jonathan Sivakumar, Jarongkorn Sirimongkolkasem, Irene Sonu, Abigail Stocker, Joseph Sujka, Jan Tack, Charles Verdonk, Xiao Jing Wang, Douglas Weinstein, John Windsor, Nicha Wongjarupong, William Xu, Natalia Zarate‐Lopez, Christopher N. Andrews, Armen A. Gharibans, Greg O'Grady   +66 more
wiley   +1 more source

Impact of Evolving Antiemetic Prophylaxis on Chemotherapy-Induced Nausea and Vomiting (CINV): A Five-Year Comparative Study in Sichuan, China (2018-2023). [PDF]

Cancer Manag Res
Xiong W, Zhang W, Zhao Q, Zheng Y, Xie K, Miao J, Chen L, Li T, Cao W, Zhu, Huang M, Li C, Wang Y, Gui Y, Li Q, Cao C, Yang Y, Du C, Gao Y, Zhou Y, Zhang H, Le X, Chen P, Jiang M, Li P, Yang J, Wang Y, Zhu J, He L.   +28 more
europepmc   +1 more source

Fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in oxaliplatin-based regimens: a prospective observational study (LODEC-N). [PDF]

Cancer Chemother Pharmacol
Iimura Y, Iihara H, Aoyama T, Hayashi T, Ishibashi M, Sasuga C, Furukawa N, Anzai E, Ijichi Y, Kuroda S.   +9 more
europepmc   +1 more source